MRI prospective survey on heart and liver iron and cardiac function in thalassemia major patients treated with Deferasirox versus Deferiprone and Desferrioxamine in monotherapy
28 August 2017 (16:30 - 16:39)
Organised by:
About the speaker

Tuscany Monasterio Foundation National Research Council, Pisa (Italy)
9 More presentations in this session

Doctor A. Pepe (Pisa, IT)

Doctor S. Quick (Chemnitz, DE)
Access the full session
The Event
ESC Congress 2017
28 August 2017
16:30 CET



